KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) EBIT (2016 - 2025)

Historic EBIT for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $386.0 million.

  • Quest Diagnostics' EBIT rose 1696.97% to $386.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 2228.43%. This contributed to the annual value of $1.3 billion for FY2024, which is 665.61% up from last year.
  • As of Q3 2025, Quest Diagnostics' EBIT stood at $386.0 million, which was up 1696.97% from $438.0 million recorded in Q2 2025.
  • Quest Diagnostics' 5-year EBIT high stood at $660.0 million for Q1 2021, and its period low was $135.0 million during Q4 2022.
  • Moreover, its 5-year median value for EBIT was $361.0 million (2024), whereas its average is $399.3 million.
  • As far as peak fluctuations go, Quest Diagnostics' EBIT soared by 27714.29% in 2021, and later tumbled by 7481.34% in 2022.
  • Over the past 5 years, Quest Diagnostics' EBIT (Quarter) stood at $536.0 million in 2021, then plummeted by 74.81% to $135.0 million in 2022, then skyrocketed by 97.78% to $267.0 million in 2023, then soared by 35.21% to $361.0 million in 2024, then rose by 6.93% to $386.0 million in 2025.
  • Its EBIT was $386.0 million in Q3 2025, compared to $438.0 million in Q2 2025 and $346.0 million in Q1 2025.